A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)
BMC cancer Volume 12 Issue 1
Page 307-
published_at 2012-07-23
Title
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)
Creators
Tsuburaya Akira
Creators
Morita Satoshi
Creators
Kodera Yasuhiro
Creators
Kobayashi Michiya
Creators
Shitara Kohei
Creators
Yamaguchi Kensei
Creators
Yoshikawa Takaki
Creators
Yoshida Kazuhiro
Creators
Sakamoto Jun-ichi
Creator Keywords
Biomarker
Capecitabine
Cisplatin
Clinical trial
Gastric cancer
S-1
Languages
eng
Resource Type
journal article
Publishers
BioMed Central
Date Issued
2012-07-23
File Version
Not Applicable (or Unknown)
Access Rights
metadata only access
Relations
[ISSN]1471-2407
[NCID]AA12034763
[PMID]info:pmid/22824079
[isVersionOf]
[URI]http://www.biomedcentral.com/bmccancer/archive/
Schools
医学部附属病院